Srdjan R. Stankovic
2019
In 2019, Srdjan R. Stankovic earned a total compensation of $5.1M as President at ACADIA Pharmaceuticals, a 10% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $517,401 |
|---|---|
| Option Awards | $1,924,767 |
| Salary | $693,563 |
| Stock Awards | $1,932,331 |
| Other | $20,208 |
| Total | $5,088,270 |
Stankovic received $1.9M in stock awards, accounting for 38% of the total pay in 2019.
Stankovic also received $517.4K in non-equity incentive plan, $1.9M in option awards, $693.6K in salary and $20.2K in other compensation.
Rankings
In 2019, Srdjan R. Stankovic's compensation ranked 2,143rd out of 13,971 executives tracked by ExecPay. In other words, Stankovic earned more than 84.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,143 out of 13,971 | 85th |
Division Manufacturing | 776 out of 5,701 | 86th |
Major group Chemicals And Allied Products | 241 out of 2,200 | 89th |
Industry group Drugs | 195 out of 1,886 | 90th |
Industry Pharmaceutical Preparations | 142 out of 1,398 | 90th |
Source: SEC filing on April 30, 2021.
Stankovic's colleagues
We found four more compensation records of executives who worked with Srdjan R. Stankovic at ACADIA Pharmaceuticals in 2019.